A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders

Fertility and Sterility

Volumn 102, Issue 1, 2014, Pages

  Yeung, Tracy Wing Yee ^a   Chai, Joyce ^a   Li, Raymond Hang Wun ^a   Lee, Vivian Chi Yan ^a   Ho, Pak Chung ^a   Ng, Ernest Hung Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

DHEA; in vitro fertilization; ovarian response markers; poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; PLACEBO; PRASTERONE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ACNE; ADULT; ANTRAL FOLLICLE COUNT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG WITHDRAWAL; ENDOMETRIAL THICKNESS; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; LOW DRUG DOSE; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE; PILOT STUDY; PREGNANCY OUTCOME; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

DHEA; IN VITRO FERTILIZATION; OVARIAN RESPONSE MARKERS; POOR RESPONDERS;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; HONG KONG; HUMANS; INFERTILITY; MENOTROPINS; OVARY; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903391195     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.03.044     Document Type: Article

References (45)

1. K.A. Vendola, J. Zhou, O.O. Adesanya, S.J. Weil, and C.A. Bondy Androgens stimulate early stages of follicular growth in the primate ovary J Clin Invest 101 1998 2622 2629
2. P. Casson, M. Lindsay, M. Pisarska, S. Carson, and J. Buster Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: A case series Hum Reprod 15 2000 2129 2132
3. A. Sen, and S.R. Hammes Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function Mol Endocrinol 24 2010 1393 1403
4. D.H. Barad, and N. Gleicher Increased oocyte production after treatment with dehydroepiandrosterone Fertil Steril 84 2005 756
5. D. Barad, and N. Gleicher Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF Hum Reprod 21 2006 2845 2849
6. D. Barad, H. Brill, and N. Gleicher Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function J Assist Reprod Genet 24 2007 629 634
7. N. Gleicher, E. Ryan, A. Weghofer, S. Blanco-Mejia, and D.H. Barad Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: A case control study Reprod Biol Endocrinol 7 2009 108
8. N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.N. Hugues Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique -A prospective, randomized, double-blind study Hum Reprod 21 2006 1204 1211
9. F. Fábregues, J. Peñarrubia, M. Creus, D. Manau, G. Casals, and F. Carmona et al. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: A randomized, clinical trial Hum Reprod 24 2009 349 359
10. C.H. Kim, C.M. Howles, and H.A. Lee The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders Fertil Steril 95 2011 679 683
11. A. Wiser, O. Gonen, Y. Ghetler, T. Shavit, A. Berkovitz, and A. Shulman Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study Hum Reprod 25 2010 2496 2500
12. S.K. Sunkara, and A. Coomarasamy Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment Fertil Steril 95 2011 e73 e74
13. Leong M, Patrizio P. Survey Results: poor responders: how to define, diagnose and treat? Results of 124,700 IVF treatment cycles (196 centres from 45 countries). IVF-Worldwide, no date (2010). Available at: http://www.ivf- worldwide.com/survey/poor-responders/results-poor-responders.html. Accessed on March 28, 2014.
14. T.W. Yeung, R.H. Li, V.C. Lee, P.C. Ho, and E.H. Ng A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency J Clin Endocrinol Metab 98 2013 380 388
15. F. Fábregues, J. Balasch, M. Creus, F. Carmona, B. Puerto, and L. Quinto et al. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome J Assist Reprod Genet 17 2000 13 19
16. D.J. Hendriks, B.W. Mol, L.F. Bancsi, E.R. te Velde, and F.J. Broekmans Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: A meta-Analysis and comparison with basal follicle-stimulating hormone level Fertil Steril 83 2005 291 301
17. H.W. Li, V.C. Lee, E.Y. Lau, W.S. Yeung, P.C. Ho, and E.H. Ng Role of baseline antral follicle count and anti-müllerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: A retrospective cohort analysis PLoS One 8 2013 e61095
18. S.L. Broer, J. van Disseldorp, K.A. Broeze, M. Dolleman, B.C. Opmeer, and P. Bossuyt et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach Hum Reprod Update 19 2013 26 36
19. T. Verhagen, D. Hendriks, L. Bancsi, B. Mol, and F. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: A meta-Analysis Hum Reprod Update 14 2008 95 100
20. L. Veeck An atlas of human gametes and conception 1999 Pathenon London
21. Z. Pandian, A.R. McTavish, L. Aucott, M. Hamilton, and S. Bhattacharya Interventions for poor 'responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst Rev 1 2010 CD004379
22. S. Weil, K. Vendola, J. Zhou, and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J Clin Endocrinol Metab 84 1999 2951 2956
23. K. Vendola, J. Zhou, J. Wang, and C.A. Bondy Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary Hum Reprod 14 1999 2328 2332
24. S.G. Hillier, and M. Tetsuka Role of androgens in follicle maturation and atresia Baillieres Clin Obstet Gynaecol 11 1997 249 260
25. M. Nielsen, I. Rasmussen, S. Kristensen, S. Christensen, K. Møllgård, and E.W. Andersen et al. In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA Mol Hum Reprod 17 2011 63 70
26. H. Wang, K. Andoh, H. Hagiwara, L. Xiaowei, N. Kikuchi, and Y. Abe et al. Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice Endocrinology 142 2001 4930 4936
27. Y.C. Hu, P.H. Wang, S. Yeh, R.S. Wang, C. Xie, and Q. Xu et al. Subfertility and defective folliculogenesis in female mice lacking androgen receptor Proc Natl Acad Sci U S A 101 2004 11209
28. N. Gleicher, A. Goyal, A. Weghofer, and D. Barad Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-müllerian hormone levels Fertil Steril 92 Suppl 2009 S54 S55
29. N. Gleicher, A. Weghofer, and D. Barad Increased euploid embryos after supplementation with dehydroepiandrosterone (DHEA) in women with premature ovarian aging Fertil Steril 88 Suppl 1 2007 S232
30. L. Mamas, and E. Mamas Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results Curr Opin Obstet Gynecol 21 2009 306
31. G. Norbert, W. Andrea, and B. David Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS) Reprod Biol Endocrinol 8 2010 140
32. M. Sönmezer, B. Ozmen, A.P. Cil, S. Ozkavukçu, T. Taşçi, and H. Olmuş et al. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders Reprod Biomed Online 19 2009 508 513
33. N. Yilmaz, D. Uygur, H. Inal, U. Gorkem, N. Cicek, and L. Mollamahmutoglu Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count Eur J Obstet Gynecol Reprod Biol 169 2013 257 260
34. N. Gleicher, A. Kim, A. Weghofer, A. Shohat-Tal, E. Lazzaroni, and H.J. Lee et al. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR) J Assist Reprod Genet 30 2013 49 62
35. N. Gleicher, A. Kim, A. Weghofer, V.A. Kushnir, A. Shohat-Tal, and E. Lazzaroni et al. Hypoandrogenism in association with diminished functional ovarian reserve Hum Reprod 28 2013 1084 1091
36. N. Gleicher, A. Weghofer, and D.H. Barad Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation Reprod Biomed Online 21 2010 360 365
37. H. Cárdenas, E. Jiménez, and W. Pope Dihydrotestosterone influenced numbers of healthy follicles and follicular amounts of LH receptor mRNA during the follicular phase of the estrous cycle in gilts Reproduction 135 2008 343 350
38. E. Klinkert, F. Broekmans, C. Looman, J. Habbema, and E. te Velde Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: A randomized controlled trial Hum Reprod 20 2005 611 615
39. M.F. Mutlu, M. Erdem, A. Erdem, S. Yildiz, I. Mutlu, and O. Arisoy et al. Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles J Assist Reprod Genet 30 2013 657 665
40. L.F. Bancsi, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization Fertil Steril 81 2004 35 41
41. D.J. Hendriks, E.R. te Velde, C.W. Looman, L.F. Bancsi, and F.J. Broekmans Expected poor ovarian response in predicting cumulative pregnancy rates: A powerful tool Reprod Biomed Online 17 2008 727 736
42. P. Saldeen, K. Källen, and P. Sundström The probability of successful IVF outcome after poor ovarian response Acta Obstet Gynecol Scand 86 2007 457 461
43. T. Timeva, T. Milachich, I. Antonova, T. Arabaji, A. Shterev, and H.A. Omar Correlation between number of retrieved oocytes and pregnancy rate after in vitro fertilization/intracytoplasmic sperm infection ScientificWorldJournal 6 2006 686 690
44. P. De Sutter, and M. Dhont Poor response after hormonal stimulation for in vitro fertilization is not related to ovarian aging Fertil Steril 79 2003 1294 1298
45. A. Ferraretti, A. La Marca, B. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: The Bologna criteria Hum Reprod 26 2011 1616 1624